INTRODUCTION
The CDP-choline pathway is the most important route of phosphatidylcholine (PtdCho) biosynthesis in different cell types, and CTP: phosphocholine cytidylyltransferase (EC 2.7.7.15) is the rate-limiting enzyme of this pathway Kent, 1990) . Its activity seems to be regulated by movement between membranes (active form) and cytosol (inactive form), especially in HeLa cells . Recently, different cytosolic forms of cytidylyltransferase were described. An inactive L-form can be converted into an active H-form, which represents a cytosolic enzyme-lipid aggregate (Weinhold et al., 1991) and is possibly identical with a complex of cytidylyltransferase in association with a 112 kDa binding protein (Feldman and Weinhold, 1993) . The translocation process has been shown to be regulated by various lipids Yao et al., 1990; Cornell, 1991a,b; Weinhold et al., 1991; Utal et al., 1991; Geilen et al., 1992a; Jamil et al., 1993) . Furthermore, there are valid indications from studies both in vivo and in vitro that PtdCho biosynthesis is, at least in part, regulated by phosphorylation/dephosphorylation of cytidylyltransferase (Hatch et al., 1990; Watkins and Kent, 1991; Hatch et al., 1992; Wang et al., 1993) , but there exists some controversy concerning the regulation of cytidylyltransferase activity by phosphorylation/dephosphorylation in vitro and the regulation of PtdCho biosynthesis in cell-culture experiments. Studies in vitro have shown that purified cytidylyltransferase is phosphorylated by cyclic AMP (cAMP)-dependent protein kinase (PKA). This phosphorylation is paralleled by an inhibition of membrane binding of cytidylyltransferase (Sanghera and Vance, 1989) . more, pulse-chase experiments revealed that H-89 did not affect cytidylyltransferase activity. Instead, H-89 inhibited choline kinase, the enzyme catalysing the first step in the CDP-choline pathway. In the presence of 10 ,M H-89, choline kinase activity was inhibited by 36 + 7.60% in vitro. Additionally, the phosphorylation of choline to phosphocholine was inhibited by 30 + 3 % in cell-culture experiments. This inhibitory effect could be partly prevented by simultaneous addition of 10 M forskolin, indicating that choline kinase is regulated in part by PKA activity.
However, cytidylyltransferase does not seem to be a substrate for PKA (Watkins et al., 1992; Jamil et al., 1992) or protein kinase C (PKC) (Utal et al., 1991) in vivo.
Recently, we reported that the potent and selective inhibitor of PKA, N-[2-bromocinnamyl(amino)ethyl]-5-isoquinolinesulphonamide (H-89) (Chijiwa et al., 1990) , inhibits the incorporation of radiolabelled choline into PtdCho in HeLa cells (Geilen et al., 1992b) . This inhibition was prevented by simultaneous addition of forskolin, whereas the choline uptake itself is not affected by H-89. In the present study, we focused our interest on the mechanism underlying the described inhibition of PtdCho biosynthesis by H-89. Our results show that H-89 inhibits PKA and, at higher concentrations, PKC, in HeLa cells, but has no effect on the phosphorylation of cytidylyltransferase. Furthermore, the distribution of cytidylyltransferase between cytosol and membranes was hardly affected, and the sn-1,2-diacylglycerol (DAG) content of the cells was not influenced at all. From (-185 TBq/ mmol) were from Amersham (Braunschweig, Germany). H-89 was obtained from Calbiochem (Bad Soden, Germany). Silica-gel 60 high-performance t.l.c. plates and reagents were purchased from Merck (Darmstadt, Germany). The BCA kit for protein determination was from Pierce (Weiskirchen, Germany). For quantification of radioactivity a t.l.c. scanner (LB2821 HR; Berthold, Wildbad, Germany) was used. Forskolin, PtdCho, protease inhibitors, histone III S, phenylenediamine, peroxidase, choline oxidase, alkaline phosphatase and phorbol 12-myristate 13-acetate (PMA) were obtained from Sigma (Miinchen, Germany). The PKA assay system was from Gibco (Karlsruhe, Germany). The alkaline phosphatase assay kit was from Behring Werke (Marburg, Germany).
Polyclonal peptide-specific antibody against cytidylyltransferase was obtained from D. E. Vance (Edmonton, Canada) and characterized previously .
Cell culture
HeLa cells were grown in Dulbecco's minimal essential medium (DMEM) supplemented with 10% heat-inactivated fetal-calf serum, 0.56 g/l glutamine, 110000 units/l penicillin and 0.1 g/l streptomycin in plastic culture dishes (Nunc, Roskilde, Denmark). Media and culture reagents were from Gibco, and antibiotics from Boehringer (Mannheim, Germany).
For radiolabelling, medium was removed, and pulse medium ([methyl-3H] Extraction, separation and quantiflcation of lipids and water-soluble metaboiltes After incubation with pulse medium, cells were washed twice with ice-cold PBS (pH 7.2) and harvested with a cell lifter (Costar; Cambridge, MA, U.S.A.) followed by modified lipid extraction as described by Bligh and Dyer (1959) . After freezedrying of the cells, 50 ,1 of methanol, 25 ,1 of chloroform and 20 ,1 of water were added. Samples were stirred for 2 min on a vortex mixer and centrifuged at 13000g for 10 min. Phase separation was accomplished by addition of 25 ,ul of chloroform and 25 ,u of water. The suspension and centrifugation steps were repeated, and 15 u1 samples of the chloroform phases were applied to silica-gel 60 high-performance t.l.c. plates with a highperformance t.l.c. applicator (Linomat III; Camag, Berlin, Germany). Then 70 ,ul portions of the upper phases were freezedried, dissolved in 20,1 of methanol/water (10:9, v/v) and likewise applied to high-performance t.l.c. plates. Lipids were separated as described by Touchstone et al. (1980) Determination of the PKC activity For this, 2.4 x 107 HeLa cells were collected in 4 ml of extraction buffer containing 20 mM triethanolamine, pH 7.4, 10 mM EGTA, 2 mM dithiothreitol, 1 mM phenylmethanesulphonyl fluoride (PMSF) and 100 ,ug/ml leupeptin. The cells were homogenized with 15 strokes in a tight-fitting Dounce homogenizer, and the homogenate was centrifuged at 150000 g for 15 min at 4 'C. The supernatant was applied to a DEAE-cellulose DE-52 column (1.5 ml), which was previously equilibrated with buffer A, containing 20 mM triethanolamine, pH 7.4, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 1 mM PMSF and 10 lOg/ml leupeptin. The column was washed with 2 x 4 ml of buffer A and eluted with buffer A containing 0.1 M NaCl. PKC activity was assayed by measuring incorporation of 32P from [y-32P]ATP into histone III S under stimulating and non-stimulating conditions. The assay mixture contained, in a total volume of 50 1l, 20 mM triethanolamine, pH 7.4, 4 mM magnesium acetate, 0.1 mM CaCl2, 50 ,tM histone III S, 50 ,#M mercaptoethanol, 20 ,tM ATP supplemented with [y-32P]ATP (final radioactivity 2 x 105 c.p.m.), purified PKC and different concentrations of H-89. Stimulation of PKC activity was achieved by adding additionally 50 ,tg/ml phosphatidylserine and 5 ,tg/ml 1,2-diolein. After incubation at 30°C for 5 min, 50 ,ul of the reaction mixture was applied to a Whatman P81 filter. The filter was washed three times with 0.05% H3PO4. Radioactivity was determined by measuring Cerenkov radiation in water.
Permeabilzatlon of cells by digitonin
For this, 6 x 106 confluent HeLa cells were incubated for 1 h in medium containing no supplement (control) or 10,uM H-89.
Cells were then washed twice with ice-cold PBS, and all the following steps were carried out at 4 'C. Buffer (300 ,u) containing 50 mM Tris/HCl (pH 7.4), 150 mM NaCl, 1 mM EDTA, 2 mM dithiothreitol, 0.025 % NaN3, 1 mM PMSF and 0.5 mg/ml digitonin was added to the cells. After incubation for 3 min, the digitonin supernatant was carefully removed. Undissolved digitonin was pelleted at 13 000 g for 2 min. The remaining ghosts of the cells in the dishes were washed with 1 ml of PBS, harvested in 50 1l of buffer as described above (the harvesting buffer contained 0.03 % Triton X-100 and no digitonin) and then homogenized with a tight-fitting Dounce homogenizer. Cytidylyltransferase activity was measured in the digitonin supernatants and in the cell ghost homogenates as described below. From the data, the ratio of cytosolic to membrane-bound cytidylyltransferase activity was calculated for each dish.
Choline kinase assay
For this, 2 x 107 HeLa cells were collected in 1 ml of extraction buffer, containing 100 mM Tris/HCI (pH 8.0), 10 mM MgCl2, 1 mM PMSF and 100 ,ug/ml leupeptin. The cells were homogenized with 15 strokes of a tight-fitting Dounce homogenizer and the homogenate was centrifuged at 150000 g for 15 min at 4°C; 20,1 of the supernatant was used for the assay.
Choline kinase activity was determined as described by Weinhold and Rethy (1974 CTP:phosphocholine cytidylyltransferase assay Cytidylyltransferase activity was measured by a modified method of Sohal and Cornell (1990) . The reaction mixture contained 50 mM Tris/HCl, pH 7.4, 0.03 % Triton X-100, 100 mM NaCl, 10 mM MgCl2, 3 mM CTP, 1.5 mM [methyl-14C]phosphocholine (sp. radioactivity 20 Bq/nmol), liposomes (400,M phosphatidylcholine/400,M oleic acid) and 10 ul of enzyme preparation in a final volume of 55 lt1. After incubation for 30 min at 37 'C the reaction was stopped by freezing the samples in liquid nitrogen. The samples were freeze-dried, dissolved in 20,l of methanol/water (1: 1, v/v) and applied to highperformance t.l.c. plates. After developing the plates in a solvent system containing methanol/0.6 % NaCl/aq. 25 % NH3 (8:5:1, by vol.), the radioactivity was determined by radioscanning.
DAG determination
The DAG assay was carried out as described by Preiss et al. (1986) . Briefly, H-89-treated and control cells were extracted by the method of Bligh and Dyer (1959) Tris/HCl (pH 7.4), 150 mM NaCl, 1 % Triton X-100, 0.1 0% SDS and 1 % sodium deoxycholate, and with pre-wash buffer, containing 10 mM Tris/HCl (pH 7.4), 1 M NaCl and 0.1 0% Nonidet P-40. Subsequently the cytosolic and particulate samples were incubated with Pansorbin cells for 30 min on ice to allow unspecific proteins to bind. After centrifuging the cells at 13 000 g for 2 min, the supernatant was incubated with the anticytidylyltransferase antibody for 1 h on ice. Again, Pansorbin cells were added and the incubation was continued for 30 min at 4 'C. The cells were spun down at 13 000 g for 30 s and the pellet was washed with 3 x 1 ml of RIPA-washing-buffer, once with 1 ml of prewash buffer and once with 1 ml of PBS. The washed cells were boiled in reducing Laemmli SDS-sample buffer and resolved on an SDS/10 %-polyacrylamide gel (Laemmli, 1970) . The dried gel was exposed to Kodak XAR-5 film for 72 h at -80°C.
Other procedures
Possible cytotoxicity of H-89 and forskolin on HeLa cells was determined by measurement of the release of alkaline phosphatase (Culvenor et al., 1981) . Protein was determined by the BCA assay (Smith et al., 1985) , with BSA as standard.
Statistical comparisons were made in these studies with Student's t test. PMA has no effect on the choline incorporation into PtdCho, which indicates that PKC is down-regulated successfully. The inhibitory effect of H-89 is prevented partly by simultaneous addition of 10 MM forskolin.
RESULTS
H-89 causes a slight translocation of cytidylyltransferase to the cytosol and has no effect on its phosphorylation Regulation of cytidylyltransferase is achieved by its translocation from the cytosol to membranes (Vance, 1989 [methyl-3H] choline (2.5 ,uCi/ml) for 2 h. Pulse medium was removed, the cells were washed three times with PBS and chase medium was added containing unlabelled choline (0.58 mM). Additionally, the chase media contained 10 ,uM H-89 or no supplements as control. The radioactivity incorporated into PtdCho was quantified as described in the Experimental section (n = 3). sol of H-89-treated cells was 6 % less than the phosphorylation of cytidylyltransferase from untreated cells (136 c.p.m. for controls and 128 c.p.m. for H-89-treated cells). These data indicate that H-89-mediated inhibition of choline incorporation into PtdCho was not due to a change in the phosphorylation of cytidylyltransferase.
A 37 kDa phosphoprotein is precipitated from the samples of membrane-associated proteins, whereas no band is seen in the 43 kDa range, where cytidylyltransferase migrates on the gel. The phosphorylation of this 37 kDa fragment is also not affected by treatment with H-89. Table 2 Effect of H-89 and forskolin on choline Incorporation into phosphocholine and PtdCho HeLa cells were grown to confluence. The medium was removed, and pulse medium was added containing [methy/-3H]choline (7.4 x 104 Bq/ml) and 1 ,M H-89, 10 ,uM H-89, 10 ,uM H-89 plus 10 ,uM forskolin or 10 ,M forskolin alone. For controls, no supplements were added. After 1 h of incubation, the cells were mechanically harvested and PtdCho and phosphocholine were analysed as described in the Experimental section. The values are given in d.p.m./,ug of cellular protein (means + S.D., n = 3; * significantly different from controls at P < 0.001). (P < 0.01). Additionally, we investigated the effect of H-89 on choline kinase activity in cell-culture experiments. Table 2 shows that H-89 inhibits the incorporation of choline not only into PtdCho but also into phosphocholine. Simultaneous addition of forskolin prevented the inhibition of choline incorporation into both phosphocholine and PtdCho, whereas forskolin alone had no effect. In these experiments it was not possible to detect significant changes in the choline and CDP-choline pool. The specific radioactivity of phosphocholine in H-89-treated cells is not decreased as compared with control cells, since the decrease in radioactivity incorporated into the phosphocholine pool is accompanied with a decrease in the actual pool size of phosphocholine in these cells. The amount of phosphocholine in control cells was 6.6 + 0.7 nmol/106 cells, which is in the same range as reported previously (Vance et al., 1980) . In HeLa cells treated with 10 4uM H-89 for I h the pool size was decreased by 50 + 10 % (n = 3).
Furthermore, pulse-chase experiments, where H-89 has no inhibitory effect on the formation of PtdCho from phosphocholine (Table 3 (Geilen et al., 1992b) .
In the present study we addressed the question of how H-89 mediates the inhibition of choline incorporation into PtdCho. Since H-89 is known to inhibit not only PKA but, in higher concentrations, also PKC, we showed that the inhibition of choline incorporation into PtdCho was not due to inhibition of PKC activity. The studies in vitro of PKA and PKC activities from HeLa cells in the presence of different H-89 concentrations clearly demonstrate that PKC activity is not influenced in the presence of 10 M H-89, whereas PKA activity is completely inhibited. Furthermore, in HeLa cells with down-regulated PKC, H-89 still inhibits choline incorporation into PtdCho.
In order to determine the block of choline incorporation, the choline labelling of the different precursors of PtdCho was measured. H-89 causes a decrease of label not only in PtdCho, but also in phosphocholine. Additionally, we determined the actual pool sizes of phosphocholine in control and H-89-treated cells, using a rapid and non-radioactive assay system. These experiments showed that the phosphocholine pool of H-89-treated cells is decreased by 500%. Since we have ruled out previously that H-89 inhibits choline uptake (Geilen et al., 1992b) , it seems reasonable that choline kinase is the main target of H-89, thereby decreasing the substrate level for cytidylyltransferase. Experiments in vitro and in vivo revealed that choline kinase activity is inhibited in the presence of 10 ,M H-89, indicating that H-89 is not so selective as promised.
Choline kinase has been shown to be stimulated by hormones, such as insulin and glucocorticoids (Oka and Perry, 1979;  Ulane and Ulane, 1980) and by cAMP analogues (Pelech et al., 1981) . Furthermore, the protein corresponding to the yeast choline kinase gene (CKI) contains two putative phosphorylation sites for PKA (Hosaka et al., 1988) . Since the formation of phosphocholine is inhibited by H-89 in vivo, a regulation of choline kinase by PKA is possible. This is supported by the observation that the inhibition of choline incorporation into phosphocholine and PtdCho can be prevented by simultaneous addition of forskolin, raising the intracellular cAMP level. Thus a higher cAMP level may overcome the H-89-mediated inhibition of choline kinase.
The next question was: Does an inhibition of PKA affect the phosphorylation of cytidylyltransferase? Immunoprecipitation of 32P-labelled cytidylyltransferase from H-89-treated and untreated cells shows that the phosphorylation state of cytidylyltransferase is not influenced by inhibition of PKA, indicating that H-89 does not influence cytidylyltransferase activity via phosphorylation/dephosphorylation. These experiments provide further evidence that cytidylyltransferase is not a substrate for PKA in vivo. This is in agreement with previous observations by other groups, who found that treatment of hepatocytes with cAMP analogues or cholera toxin has no effect on the phosphorylation of cytidylyltransferase (Watkins et al., 1992; Jamil et al., 1992) .
The antibody also precipitates a membrane-associated phosphoprotein with an apparent molecular mass of 37 kDa. We suggest that the 37 kDa band represents a membrane-bound protein that is co-precipitated by the antibody. Since other groups also detected a 37 kDa band with a different anticytidylyltransferase antibody in extracts of insect cells infected with a recombinant baculovirus containing rat cytidylyltransferase cDNA (Luche et al., 1993) , it is possible that the 37 kDa band is a fragment or a precursor of cytidylyltransferase. However, the phosphorylation of the 37 kDa protein was also not altered. As a possible mechanism for H-89-mediated inhibition of choline incorporation into PtdCho, we investigated the influence of H-89 on the distribution of cytidylyltransferase between cytosol and membranes. Our data show that H-89 causes a slight translocation of the enzyme from membranes to the cytosol, but the decrease in membrane-bound cytidylyltransferase of about 20 % does not correlate with an inhibition of choline incorporation into PtdCho of 50 %. These data are in agreement with the results concerning the DAG content of the cells. DAG is known to signal translocation of cytidylyltransferase to membranes (Utal et al., 1991) and a decrease in the cellular DAG level could be responsible for the observed translocation of cytidylyltransferase to the cytosol. Since the DAG content in the cells is not altered after H-89 treatment, we think that the slight translocation of cytidylyltransferase might result from detergent-like effects of H-89. The hypothesis that cytidylyltransferase is not a target of H-89 is supported by pulse-chase experiments, where H-89 has no effect on choline incorporation into PtdCho.
In conclusion, in experiments using H-89 as an inhibitor of PKA, we found that other kinases, such as choline kinase, might also be targets of H-89.
